<DOC>
	<DOCNO>NCT00050284</DOCNO>
	<brief_summary>The purpose study determine whether patient asymptomatic HIV infection discontinue antiretroviral therapy ( ART ) without adverse clinical , virologic , immunologic consequence . This study also assess virologic , immunologic , clinical outcome patient restart ART .</brief_summary>
	<brief_title>Discontinuation Antiretroviral Therapy Patients With Asymptomatic HIV Infection</brief_title>
	<detailed_description>Patients discontinue ART without significant loss virologic immunologic control without increase clinical event may spar expense adverse effect treatment . However , consequence treatment discontinuation patient asymptomatic HIV infection well understood . This study follow clinical immunologic progression HIV infection patient low HIV viral load preserve CD4+ cell count time ART stop . Patients fast least 8 hour prior first study visit . At visit , blood drawn body measurement take . Patients discontinue ART . Patients take nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) stop take NNRTIs 48 hour withdraw ART drug . Study visit occur every 4 8 week first year , every 12 week second year . Blood take visit , patient ask fast least 8 hour prior Week 12 24 visit every 6 month . Patients reinitiate ART reason register Step 2 follow 24 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>HIV infection ART 2 drug 6 month CD4+ cell count ( ) &gt; 350 cells/mm3 immediately prior initiation first ART CD4+ cell count &gt; 350 cells/mm3 within 45 day prior study entry Plasma viral load &lt; 55,000 copies/ml within 45 day prior study entry Willingness discontinue ART study entry Negative serum urine pregnancy test within 14 day prior study entry Pregnancy breastfeed Systemic cancer chemotherapy , systemic investigational agent , immunomodulators within 30 day prior study entry Drug alcohol use dependence would interfere adherence study requirement Illness require systemic treatment and/or hospitalization patient either complete therapy clinically stable therapy least 30 day prior study entry Chronic medical condition would negative impact participation patient would expect result significant use medical care system History HIVrelated illness complication CDC categories B C Nonadherence ART Active infection hepatitis B currently take adefovir dos &gt; 10 mg 3TC and/or TDF</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>Disease Progression</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Treatment Interruption</keyword>
</DOC>